Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2021-07-09 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates and the request for issuance of duplicate share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an official notification about a shareholder's lost share certificates and does not contain financial data, earnings, management changes, or other report types. It is a regulatory announcement related to shareholding but not a major shareholding notification (which involves crossing ownership thresholds). It is not a report or presentation but a compliance disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. The document length is short (2818 characters), and it is not an announcement of a report but a direct notification. Confidence is high due to clear regulatory context and content type.
2021-07-09 English
Defaults on Payment of Interest/Principal
Regulatory Filings Classification · 95% confidence The document is a quarterly disclosure submitted to stock exchanges (NSE and BSE) regarding the status of defaults on payment of interest/repayment of principal on loans and unlisted debt securities, pursuant to SEBI Circular no. SEBI/HO/CFD/CMD1/CIR/P/2019/140 dated November 21, 2019. It references a previous quarterly disclosure and provides updated details on the company's debt status, including no defaults on bank loans and details on cumulative redeemable preference shares. The document includes financial figures as of the quarter ended June 30, 2021, and is a regulatory compliance disclosure rather than a full financial report. It is not an earnings release, annual or interim report, or audit report. It is a regulatory filing made to comply with SEBI requirements about debt default disclosures. The document length is about 5,646 characters, which is sufficient for a detailed disclosure but not a full financial report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-07-08 English
Defaults on Payment of Interest/Principal
Regulatory Filings Classification · 95% confidence The document is a quarterly disclosure regarding the status of defaults on payment of interest/repayment of principal amount on loans and unlisted debt securities, pursuant to a SEBI circular dated November 21, 2019. It provides specific financial data as of June 30, 2021, including amounts outstanding and defaults. The document is relatively short (2339 characters) and is a regulatory compliance disclosure rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). Instead, it is a regulatory filing to comply with SEBI requirements about debt default status disclosures. Therefore, it fits best under Regulatory Filings (RNS).
2021-07-07 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of a share certificate and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an official notification about a shareholder's lost share certificate and does not contain financial data, management discussion, or report content. It is not a financial report, earnings release, or management report. It is also not a voting result, capital change, or director dealing. The document is a regulatory announcement informing the stock exchanges about a specific event related to share certificates. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-07-07 English
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 06th July, 2021, ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of a share certificate and the request for issuance of a duplicate share certificate. It references Regulation 39(3) of the SEBI Listing Obligations and Disclosure Requirements, which pertains to share certificate loss and related disclosures. The content is an official notification about a specific shareholder's lost share certificate and does not contain financial data, management discussion, or report content. It is not an annual report, earnings release, or any financial report. It is also not a voting result, board change, or capital change announcement. The document is a regulatory announcement related to share certificate loss, which fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure to the stock exchanges without substantive financial or strategic content.
2021-07-07 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the production of a test batch of the Sputnik V vaccine in India by Morepen Laboratories in partnership with the Russian Direct Investment Fund (RDIF). It is addressed to stock exchanges and intended for public dissemination. The content focuses on the announcement of a business development and partnership related to vaccine production, without any financial statements, regulatory filings, or detailed financial data. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is a corporate announcement about a strategic partnership and production milestone, which aligns best with a Capital/Financing Update (CAP) as it relates to business expansion and production capacity updates. The document length is 8385 characters, which is substantial but the content is clearly a press release rather than a financial report or regulatory filing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-07-06 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.